Kyung Hee East-West Neo Medical Center
Seoul, 134-090, South Korea
NCT Number: NCT00911768
The purpose of this study is to determine the effect of KRG (Korean Red Ginseng) on Dry Mouth (Xerostomia).
Looking for future studies?
Notify Me19 year–76 year
All sexes
Interventional
Phase 4
Seoul, 134-090, South Korea
Korean Red Ginseng
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Generic name: Korean Red Ginseng Powder Capsule Original herb name: Panax ginseng Form and contents: Capsule with powder of steamed root of 6-year Panax ginseng Dosage and frequency: 6 g per day (twice a day), Oral administration Administration duration: 56 days in the study
Other names: Brand Name: Korean Red Ginseng Powder Capsule
There is no specific name because this intervention is placebo. This placebo has the same form, color and flavor as Korean Red Ginseng Powder Capsule.
The dosage form, dosage, frequency and duration is also same as experimental intervention (Korean Red Ginseng Powder Capsule).
Main contents: corn-starch with Panax ginseng flavor
Other names: Corn-starch powder capsule with Korean Red Ginseng flavor
Time frame: 8 weeks
Visual Analogue Scale of Subjective Dry Mouth is 10 cm, where 0 cm indicates no dry mouth and 10 cm the severe dry mouth.
Time frame: 8 weeks
Stimulated salivary flow rates were compared between 0 and 8 weeks in both groups.
Time frame: 8 weeks
Unstimulated salivary flow rates were compared between 0 and 8 weeks in both groups.
The Korean Society of Ginseng
Other
PMS Clinical Study of Korean Red Ginseng Powder on Dry Mouth and Salivary Flow Rates in Xerostomatic Populations
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02057510
Dental Disease, Head and Neck Cancer
Farmington, Connecticut, United States
View Trial DetailsNCT04222478
Mouth Diseases, Salivary Gland Diseases
Brest, Brittany Region, France
View Trial DetailsNCT04645693
Caries, Disease Attributes
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07555444
Hyposalivation, Mouth Diseases
São Paulo, Brazil
View Trial Details